Ziebell Mark R 4
4 · Avid Bioservices, Inc. · Filed May 2, 2024
Insider Transaction Report
Form 4
Ziebell Mark R
VP and General Counsel
Transactions
- Sale
Common Stock, $0.001 par value
2024-04-30$7.40/sh−1,643$12,157→ 64,834 total
Footnotes (2)
- [F1]Represents the shares sold by the reporting person pursuant to a contractual election to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSUs") which vested on April 9, 2024. This sale does not represent a discretionary trade by the reporting person. For further information regarding the RSUs vested on April 9, 2024, refer to footnotes 2, 3 and 4 of the reporting person's Form 4 filed with the SEC on April 11, 2024.
- [F2]Represents a weighted average sales price per share. These shares were sold at prices ranging from $7.33 to $7.40. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.